Development and Validation of the Pediatric Nausea Assessment Tool for Use in Children Receiving Antineoplastic Agents

Dupuis, L. Lee; Taddio, Anna; Kerr, Elizabeth; Kelly, Andrea; MacKeigan, Linda

doi:10.1592/phco.26.9.1221

Cited by 105 publications

(94 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…11 Ten percent were excluded for failure to understand the term nausea. Only moderate correlation was noted between PeNAT scores and parental assessment of nausea on a VAS scale, with the test-retest reliability not achieving the criterion value in all groups.…”

Section: Discussionmentioning

confidence: 99%

“…9,10 Caretaker assessments underestimate subjective symptoms, but existing pediatric self-report scales for estimating nausea severity have only moderate construct and convergent validity scores. [11][12][13] By default, emesis is the most common objective outcome used in pediatric nausea studies but may not correlate with the symptom of nausea. 14 In adults, the visual analog scale (VAS) is a validated self-assessment tool for measuring the severity of nausea (VAS-N) and pain (VAS-P).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Development and Validation of a Pictorial Nausea Rating Scale for Children

Baxter¹,

Watcha

Baxter³

et al. 2011

Pediatrics

126

View full text Add to dashboard Cite

OBJECTIVE: The lack of a widely used, validated measure limits pediatric nausea management. The goal of this study was to create and validate a pictorial scale with regular incremental levels between scores depicting increasing nausea intensity. METHODS: A pictorial nausea scale of 0 to 10 with 6 faces (the Baxter Retching Faces [BARF] scale) was developed in 3 stages. The BARF scale was validated in emergency department patients with vomiting and in healthy patients undergoing day surgery procedures. Patients were presented with visual analog scales for nausea and pain, the pictorial Faces Pain Scale–Revised, and the BARF scale. Patients receiving opioid analgesics or antiemetic agents had their pain and nausea assessed before and 30 minutes after therapy. Spearman's ρ correlation coefficients were calculated. A Wilcoxon matched-pair rank test compared pain and nausea scores before and after antiemetic therapy. RESULTS: Thirty oncology patients and 15 nurses participated in the development of the scale, and 127 patients (52, emergency department; 75, day surgery) ages 7 to 18 years participated in the validation. The Spearman ρ correlation coefficient of the first paired BARF and visual analog scale for nausea scores was 0.93. Visual analog scales for nausea and BARF scores (P = .20) were significantly higher in patients requiring antiemetic agents and decreased significantly after treatment, while posttreatment pain scores (P = .47) for patients receiving only antiemetic agents did not. CONCLUSIONS: We describe the development of a pictorial scale with beginning evidence of construct validity for a self-report assessment of the severity of pediatric nausea. The scale had convergent and discriminant validity, along with an ability to detect change after treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

Development and Validation of a Pictorial Nausea Rating Scale for Children

Baxter¹,

Watcha

Baxter³

et al. 2011

Pediatrics

126

View full text Add to dashboard Cite

show abstract

“…Chemotherapy-induced nausea in adolescents has been measured using the Pediatric Nausea Assessment Tool (PeNAT), a tool with a 4-point facial expressions item, developed for ages 4 to 18. 28 Walker et al 29 measured sleep-wake disturbances in adolescents with cancer (ages 10 to 19) using the Adolescent Sleep-Wake Scale, developed for healthy adolescents. 30 Dyson et al 31 assessed depressive symptoms and anxiety in AYAs (ages 16 to 30) using the Beck Depression Inventory 2 nd edition Fast Screen (BDI-FS) 32 and the State Trait Anxiety Inventory-State form (STAI-S).…”

Section: Resources For Measuring Symptoms and Symptom Clustersmentioning

confidence: 99%

Measures and Methods for Symptom and Symptom Cluster Assessment in Adolescents and Young Adults with Cancer

Linder¹,

Ameringer

Baggott

et al. 2015

Seminars in Oncology Nursing

View full text Add to dashboard Cite

“…A higher number of publications per PRO were associated with higher quality as subsequent publications assessed quantitative aspects such as longitudinal assessments and minimally important differences. The PROs cover a range of conditions, including achalasia (23), celiac sprue (24,25), dyspepsia (26–43), eosinophilic esophagitis (44), fecal incontinence (45–60), functional GI disorders (25,41,49,53,60–86), gastroesophageal reflux disease (30,38–40,43,87–110), GI malignancies (48,77,111–115), postgastrectomy (113,116), ileal conduit diversion (117), ileostomy (118), inflammatory bowel disease (119–127), pregnancy-related GI symptoms (128–130), systemic sclerosis (131–133), and radiation enteritis (57), among others. In all, 15 PROs apply to the pediatric population (44,45,60,77,80,97,100,102,115,123,124,134–137), and 6 apply specifically to women (56,128–130,138,139).…”

Section: Resultsmentioning

confidence: 99%

“…Our search revealed 11 PROs with items pertaining to nausea and vomiting (44,66,110,115,128–130,136,137, 140,148,149). These items capture a range of increasingly severe foregut symptoms that begins with feeling sick to the stomach and ends with vomiting up stomach contents.…”

Section: Resultsmentioning

confidence: 99%

Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database

Khanna

Agarwal

Khanna

et al. 2014

American Journal of Gastroenterology

View full text Add to dashboard Cite

OBJECTIVES Because gastrointestinal (GI) illnesses can cause physical, emotional, and social distress, patient-reported outcomes (PROs) are used to guide clinical decision making, conduct research, and seek drug approval. It is important to develop a mechanism for identifying, categorizing, and evaluating the over 100 GI PROs that exist. Here we describe a new, National Institutes of Health (NIH)-supported, online PRO clearinghouse—the GI-PRO database. METHODS Using a protocol developed by the NIH Patient-Reported Outcome Measurement Information System (PROMIS®), we performed a systematic review to identify English-language GI PROs. We abstracted PRO items and developed an online searchable item database. We categorized symptoms into content “bins” to evaluate a framework for GI symptom reporting. Finally, we assigned a score for the methodological quality of each PRO represented in the published literature (0–20 range; higher indicates better). RESULTS We reviewed 15,697 titles (κ > 0.6 for title and abstract selection), from which we identified 126 PROs. Review of the PROs revealed eight GI symptom “bins”: (i) abdominal pain, (ii) bloat/gas, (iii) diarrhea, (iv) constipation, (v) bowel incontinence/soilage, (vi) heartburn/reflux, (vii) swallowing, and (viii) nausea/vomiting. In addition to these symptoms, the PROs covered four psychosocial domains: (i) behaviors, (ii) cognitions, (iii) emotions, and (iv) psychosocial impact. The quality scores were generally low (mean 8.88±4.19; 0 (min)−20 (max)). In addition, 51% did not include patient input in developing the PRO, and 41% provided no information on score interpretation. CONCLUSIONS GI PROs cover a wide range of biopsychosocial symptoms. Although plentiful, GI PROs are limited by low methodological quality. Our online PRO library (www.researchcore.org/gipro/) can help in selecting PROs for clinical and research purposes.

show abstract

Development and Validation of the Pediatric Nausea Assessment Tool for Use in Children Receiving Antineoplastic Agents

Abstract: The PeNAT is a new instrument that can be used by children to assess nausea intensity.

Cited by 105 publications

References 28 publications

Development and Validation of a Pictorial Nausea Rating Scale for Children

Development and Validation of a Pictorial Nausea Rating Scale for Children

Measures and Methods for Symptom and Symptom Cluster Assessment in Adolescents and Young Adults with Cancer

Development of an Online Library of Patient-Reported Outcome Measures in Gastroenterology: The GI-PRO Database

Contact Info

Product

Resources

About